levensten law firm logo

Initial Conference in Pradaxa Multidistrict Litigation set for October 3, 2012

Boehringer Ingelheim is now facing Multidistrict litigation over its dangerous drug, Pradaxa. The Pradaxa litigation was assigned to Chief Judge, David R. Herndon of the Southern District of Illinois. To date, Case Managment Order No. 1, Initial Conference Order and Procedural Matters, setting the initial conference for 10/3/2012 01:30 PM in East St. Louis Courthouse; […]

Profits over Patient Safety: Pradaxa TV Commercials Continue To Flood The Networks

Steps taken by the international pharmaceutical corporation Boehringer Ingelheim pursuant to the development of Pradaxa, an FDA – approved prescription medicine designed to help reduce the risk of stroke in persons with nonvalvular atrial fibrillation, demonstrate the company’s purely profit – driven motivation with respect to the drugs distribution. Moreover, Pradaxa is expected to be […]

Pradaxa has Woefully Inadequate Warnings and Precautions About Serious Bleeding Risks

Despite the serious risks associated with daily usage of Pradaxa, Boehringer Ingelheim, the drugs creator, fails to adequately warn patients of the dangers involved. Evidence of this claim is demonstrated when reviewing a study issued by the Institute for Safe Medication Practices, which reported that out of the 272,119 prescriptions issued for Pradaxa in the […]


Your Warriors for Justice
Fight fearlessly. Win strategically.